I am a retail pharmacist working in a busy chain pharmacy. A patient came in and requested a temporary supply of his Crestor 40 mg tablets because he had run out of tablets before he was eligible for a refill through insurance. I checked his profile and noticed that it had been 1 1/2 months since his last 90 day refill so I asked why he had run out. He said that his doctor had told him to double up and take 80 mg daily. This didn't sound correct, but it was after office hours and the patient was adamant that these were his doctor's instructions and that he would have to stop his medication if I didn't dispense to him.
Read More »Alcohol and Diabetes: How Alcohol Affects Diabetes
While there are a number of factors that can negatively impact adherence to self-care in a person with diabetes, this article will focus on diabetes and alcohol: specifically, on how alcohol consumption limits this adherence and affects the overall health of people with diabetes.
Read More »Diabetes Increases Risk of Surgical Site Infections
A meta-analysis reveals that the risk is present for most surgeries.
Read More »Study Suggests Caution Needed When Using Premixed Insulin in the Hospital
New study suggests that in hospital patients with T2DM, premixed insulin provides similar glycemic control as a basal-bolus insulin regimen.
Read More »Safety and Efficacy of Vildagliptin and Sitagliptin in Renally Impaired Type 2 Diabetics
Dipeptidyl peptidase-4 (DPP4) inhibitors are generally well-tolerated for use in patients with severe renal impairment...
Read More »Best Plan for Patient May Not Be The Recommended Plan
Female, type 1 diabetes for 42 years, 58 years of age, lives with husband and dog. Patient has hypoglycemic unawareness. We regularly readjust her treatment plan and have recommended CGM for this patient on numerous occasions, but she refuses, stating her dog wakes her up if and when she has …
Read More »Efficacy and Safety of an SGLT-2 Inhibitor with Insulin for Type 2s
Canagliflozin appears to offer significant benefits when used in conjunction with insulin therapy.
Read More »FDA Panel Recommends New CV Safety Warnings on Onglyza and Nesina DPP-4s
Updated label information recommendation is in light of completed cardiovascular-outcomes studies.
Read More »Clinical Trial Examines Safety, Effectiveness of Drug to Treat Binge Eating Disorder
Lisdexamfetamine dimesylate, used to treat attention-deficit/hyperactivity disorder, was effective compared with placebo in decreasing binge-eating (BE) days in patients… At some doses, the medication lisdexamfetamine dimesylate, a drug approved to treat attention-deficit/hyperactivity disorder, was effective compared with placebo in decreasing binge-eating (BE) days in patients with binge-eating disorder (BED), a …
Read More »Dosing Error Due to Accent Misinterpretation
When reviewing the medical record of a hospital patient prior to meeting with her for a diabetes consult, I noted that the doctor had ordered 46 units of Lantus to be given daily at bedtime. When I went in to visit with the patient, she had a very strong accent …
Read More »